Article
13 Aug 2025
Continued Efforts To Onshore Pharmaceutical Manufacturing: FDA Announces New FDA PreCheck Program
AUTHORS CONTENT
Article
08 Aug 2025
Implications Of FDA's "Radical Transparency" Plan For Complete Response Letters
Article
29 Jul 2025
FDA Begins To Accept Nominations For The Commissioner's National Priority Voucher Pilot Program
Article
23 Jun 2025
FDA Announces Commissioner's National Priority Vouchers To Facilitate Expedited Access To Certain Drugs
Article
20 May 2025
Former FDA Officials Howard Sklamberg And Eva Temkin Share Insights On AI's Role In Drug Development On FDA Watch Podcast
Article
14 May 2025
President Trump Issues Executive Order On Regulatory Relief To Promote Domestic Production Of Critical Medicines
Article
22 Apr 2025
Trump Administration Issues Executive Order To Lower Prescription Drug Costs
Article
21 Apr 2025
Trump Administration Takes Next Steps Toward Pharmaceutical Tariffs
Article
04 Apr 2025
LDTs Are Not Devices Under The FDCA: Eastern District Of Texas Vacates FDA Final Rule On LDTs
Article
20 Feb 2025
A First Look At The MAHA Era: Initial Thoughts For Industry Based On The MAHA Commission EO
Article
18 Feb 2025
The DOGE Workforce Optimization EO: Implications For FDA
Article
03 Feb 2025
Late Guidance Push By Biden Administration Over Clinical Trial Diversity Faces New Obstacles From Recent Trump Executive Orders
Article
30 Jan 2025
FDA Finalizes Rule On ACNU Drugs, Signaling Opening For Next-Gen OTC Drugs
Article
16 Jan 2025
FDA Issues New Draft Guidance On Getting Confirmatory Trials "Underway" For Accelerated Approvals
Article
16 Jan 2025
FDA Finalizes Its SIUU Guidance: An Analysis Of The Key Changes From The 2023 Draft Guidance
Article
27 Dec 2024
Recent SEC Case Against Biotech Company Highlights The Intersection Between FDA Findings And SEC Enforcement
Article
17 Dec 2024
FDA Issues New Draft Guidance For Expedited Program For Serious Conditions — Accelerated Approval Of Drugs And Biologics
Article
15 Jul 2024
FDA Issues Revised Draft Guidance On Addressing Misinformation About Medical Devices And Prescription Drugs
Article
11 Jul 2024
When APA Claims Accrue Under Corner Post: Implications For The Life Sciences Industry
Article
03 Jul 2024
Chevron Overturned: What Does It Mean For Life Sciences Companies?